Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
LuZfKWabF8CByE9M
